Document is current
Any future updates will be listed below
-
Authors
Steiner, Annemarie
Hrovat-Schaale, Katja https://orcid.org/0000-0002-0398-5015
Prigione, Ignazia
Yu, Chien-Hsiung https://orcid.org/0000-0003-1744-3791
Laohamonthonkul, Pawat
Harapas, Cassandra R.
Low, Ronnie Ren Jie https://orcid.org/0000-0002-2629-4778
De Nardo, Dominic https://orcid.org/0000-0002-7045-4695
Dagley, Laura F. https://orcid.org/0000-0003-4171-3712
Mlodzianoski, Michael J. https://orcid.org/0000-0002-3510-9167
Rogers, Kelly L. https://orcid.org/0000-0002-6755-0221
Zillinger, Thomas https://orcid.org/0000-0002-0866-4835
Hartmann, Gunther https://orcid.org/0000-0003-1021-2018
Gantier, Michael P.
Gattorno, Marco
Geyer, Matthias https://orcid.org/0000-0002-7718-5002
Volpi, Stefano https://orcid.org/0000-0002-7129-868X
Davidson, Sophia
Masters, Seth L. https://orcid.org/0000-0003-4763-576X
-
Funding
Funding for this research was provided by:
Sylvia and Charles Viertel Charitable Foundation (VTL2016F027)
Wellcome Trust (208694/Z/17/Z)
- License Information
-
More Information
Article History
Received: 17 July 2020
Accepted: 5 April 2022
First Online: 28 April 2022
Competing interests
: M.Ga. declares consultancy and speakers fee from Novartis and SOBI. S.L.M. receives funding from IFM therapeutics and M.Ge. consults to IFM Therapeutics. The other authors declare no competing interests.
